Message from the Directors

Mount Sinai's Adult Liver Transplant Program is one of the largest and oldest programs in the country. Because of our reputation as one of the nation's leading liver transplant programs and our history as a tertiary referral center for patients with all forms of liver disease, we often tackle the complex problems of very sick patients. We give every patient equal consideration in terms of clinical eligibility for transplant. We do this in a compassionate and individualized manner, a hallmark of the Transplantation Institute at Mount Sinai.

Our multidisciplinary team comprises experts in hepatology, surgery, surgical oncology, anesthesiology, critical care, transplant immunology, and virology. This interdisciplinary approach enables us to provide the best in patient care, using state-of-the-art technologies and surgical techniques. 

We remain vigilant in maintaining close working relationships with our referring physicians. The subspecialists and basic researchers that we collaborate with are some of the leaders in their field. Both the Division of Liver Diseases and the Department of Surgical Oncology are nationally and internationally known, as are our transplant hepatology and transplant surgery fellowships.

Advances in care

Our innovative treatments include:

• Adult live donor liver transplantation, which Mount Sinai helped pioneer, in which a living donor gives part of his or her liver to save somebody’s life
• Split-liver transplantation, in which one donor’s liver is split in two to save two people
• Multiorgan abdominal transplantation, often a kidney in conjunction with one or more other organs
• A multidisciplinary approach to patients with liver disease and intestinal failure
• Complex surgery for patients with difficult-to-manage portal hypertension
• A multidisciplinary approach to patients with liver and biliary cancer
• Novel drug treatment trials for viral hepatitis, HIV, primary biliary cirrhosis, autoimmune hepatitis, hepatic fibrosis, as well as new immunosuppressive agents
• Expertise in treating patients with complex vascular diseases of the liver, including Budd-Chiari syndrome, portal vein thrombosis, mesenteric vein thrombosis, and non-cirrhotic portal hypertension
• Care for patients having HIV who have chronic liver disease and are in need of a liver transplant
• A multi-department team approach to the treatment of fulminant liver failure; the team includes experts in critical care, hematology, neurology, neurosurgery, and anesthesiology

Extending our reach

In order to provide our services to as many patients as possible, we have developed outreach programs with Monmouth and Englewood hospitals in New Jersey, Richmond University Hospital in Staten Island, and Elmhurst Hospital in Queens. We are establishing and consolidating additional outreach relationships in Brooklyn, Westchester, and Long Island. 

We have a 24-hour transfer service and referral line so that critically ill patients can be transferred quickly to Mount Sinai for treatment. Liver transplant patients and their families can stay at our guest house, the Transplant Living Center. The guest house is located within walking distance of the hospital, providing families the opportunity to be with their loved one throughout the entire liver transplant process.

We take great pride in the quality of care we provide our patients, and we will continue to strengthen our relationships with our patients, their families, and their referring physicians.

Thomas D. Schiano, MD
Medical Director, Adult Liver Transplantation
Director, Clinical Hepatology

Sander S. Florman, MD
Director, Recanati Miller Transplantation Institute